Matas Misevicius

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Emergency Department

Anti Inflammatory

Induced Pluripotent Stem Cells

Respiratory Syndrome Coronavirus

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara Farkaš, Marco Minneci, Matas Misevicius, Isabel Rozas
A Tale of Two Proteases: M Pro and TMPRSS2 as Targets for COVID-19 Therapies. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Barbara Farkaš, Marco Minneci, Matas Misevicius, Isabel Rozas
A Tale of Two Proteases: M Pro and TMPRSS2 as Targets for COVID-19 Therapies. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)